AP2029A - Microcapsules for the delayed, controlled release of perindopril - Google Patents

Microcapsules for the delayed, controlled release of perindopril

Info

Publication number
AP2029A
AP2029A AP2004003193A AP2004003193A AP2029A AP 2029 A AP2029 A AP 2029A AP 2004003193 A AP2004003193 A AP 2004003193A AP 2004003193 A AP2004003193 A AP 2004003193A AP 2029 A AP2029 A AP 2029A
Authority
AP
ARIPO
Prior art keywords
perindopril
microcapsules
delayed
controlled release
release
Prior art date
Application number
AP2004003193A
Other languages
English (en)
Other versions
AP2004003193A0 (en
Inventor
De Barochez Bruno Huet
Patrick Wuthrich
Valerie Legrand
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2004003193A0 publication Critical patent/AP2004003193A0/xx
Application granted granted Critical
Publication of AP2029A publication Critical patent/AP2029A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2004003193A 2002-06-24 2003-06-24 Microcapsules for the delayed, controlled release of perindopril AP2029A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207778A FR2841140B1 (fr) 2002-06-24 2002-06-24 Microcapsules pour la liberation retardee et controlee du perindopril
PCT/FR2003/001931 WO2004000286A1 (fr) 2002-06-24 2003-06-24 Microcapsules pour la liberation retardee et controlee du perindopril

Publications (2)

Publication Number Publication Date
AP2004003193A0 AP2004003193A0 (en) 2004-12-31
AP2029A true AP2029A (en) 2009-08-24

Family

ID=29719985

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2004003193A AP2029A (en) 2002-06-24 2003-06-24 Microcapsules for the delayed, controlled release of perindopril

Country Status (37)

Country Link
US (1) US20060165808A1 (ru)
EP (1) EP1515704B1 (ru)
JP (1) JP4723243B2 (ru)
KR (1) KR100722082B1 (ru)
CN (1) CN100345541C (ru)
AP (1) AP2029A (ru)
AR (1) AR040461A1 (ru)
AT (1) ATE429214T1 (ru)
AU (1) AU2003260620B2 (ru)
BR (1) BR0312026A (ru)
CA (1) CA2491172C (ru)
CR (1) CR7648A (ru)
CY (1) CY1109154T1 (ru)
DE (1) DE60327318D1 (ru)
DK (1) DK1515704T3 (ru)
EA (1) EA007571B1 (ru)
EC (1) ECSP055570A (ru)
ES (1) ES2326218T3 (ru)
FR (1) FR2841140B1 (ru)
GE (1) GEP20074212B (ru)
HR (1) HRP20050055B1 (ru)
IL (1) IL165896A0 (ru)
IS (1) IS2679B (ru)
MA (1) MA27262A1 (ru)
ME (1) ME00452B (ru)
MX (1) MXPA05000086A (ru)
NO (1) NO20050163L (ru)
NZ (1) NZ537408A (ru)
OA (1) OA12875A (ru)
PL (1) PL374377A1 (ru)
PT (1) PT1515704E (ru)
RS (1) RS50914B (ru)
SI (1) SI1515704T1 (ru)
TN (1) TNSN04259A1 (ru)
UA (1) UA81121C2 (ru)
WO (1) WO2004000286A1 (ru)
ZA (1) ZA200410333B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FI125776B2 (fi) 2008-06-27 2023-07-28 Metsaeliitto Osuuskunta Menetelmä puulevyn käsittelemiseksi
CN106983731A (zh) * 2017-04-20 2017-07-28 上药东英（江苏）药业有限公司 一种培哚普利控释片及其制备方法
DE102018123500A1 (de) 2018-09-25 2020-03-26 Man Energy Solutions Se Vorrichtung und Verfahren zur Einstellung der Länge einer Pleuelstange eines Zylinders einer Brennkraftmaschine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056355A1 (de) * 1997-06-12 1998-12-17 Hexal Ag Kontrolliert freisetzende pharmazeutische zubereitung mit einem ace-hemmer als wirkstoff
WO1999025374A1 (fr) * 1997-11-19 1999-05-27 Adir Et Compagnie Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
GB2352172A (en) * 1999-05-11 2001-01-24 West Pharm Serv Drug Res Ltd Orally administered dose unit comprising a drug with an outer coating of an enteric polymer, which allows co-administered food to separate from the dose unit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2247186A1 (de) * 1972-09-26 1974-03-28 Bayer Ag Antimykotisches mittel
JPS55129219A (en) * 1979-03-29 1980-10-06 Asahi Chem Ind Co Ltd Slow-releasing preparation
EP1442745A1 (en) * 1993-10-07 2004-08-04 Euro-Celtique Orally administrable opioid formulations having extended duration of effect
JPH11171769A (ja) * 1997-12-05 1999-06-29 Nichiko Pharmaceutical Co Ltd ３−イソブチリル−２−イソプロピルピラゾロ〔１，５−ａ〕ピリジンの徐放性製剤及びその製法
JP2004501099A (ja) * 2000-05-11 2004-01-15 フアルマシア　コーポレイション アルドステロン頂点位相時の放出のためのアルドステロンアンタゴニスト組成物
DE60325709D1 (de) * 2002-04-09 2009-02-26 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
CN1189150C (zh) * 2002-11-07 2005-02-16 张凤英 祛斑美白面膜
CN100389300C (zh) * 2004-01-17 2008-05-21 湖北清江水布垭工程建设公司 大坝面板挠度或坝体内部变形监测方法及装置

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056355A1 (de) * 1997-06-12 1998-12-17 Hexal Ag Kontrolliert freisetzende pharmazeutische zubereitung mit einem ace-hemmer als wirkstoff
WO1999025374A1 (fr) * 1997-11-19 1999-05-27 Adir Et Compagnie Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
GB2352172A (en) * 1999-05-11 2001-01-24 West Pharm Serv Drug Res Ltd Orally administered dose unit comprising a drug with an outer coating of an enteric polymer, which allows co-administered food to separate from the dose unit

Also Published As

Publication number Publication date
ES2326218T3 (es) 2009-10-05
NZ537408A (en) 2006-07-28
AP2004003193A0 (en) 2004-12-31
WO2004000286A1 (fr) 2003-12-31
ME00452B (me) 2011-10-10
AU2003260620B2 (en) 2008-07-31
NO20050163L (no) 2005-01-12
HRP20050055B1 (hr) 2013-11-08
CA2491172A1 (fr) 2003-12-31
EP1515704A1 (fr) 2005-03-23
ZA200410333B (en) 2006-07-26
CA2491172C (fr) 2011-02-15
DK1515704T3 (da) 2009-07-20
CR7648A (es) 2005-07-18
JP2005533079A (ja) 2005-11-04
UA81121C2 (en) 2007-12-10
KR100722082B1 (ko) 2007-05-25
MA27262A1 (fr) 2005-03-01
SI1515704T1 (sl) 2009-08-31
RS50914B (sr) 2010-08-31
EA200500030A1 (ru) 2005-06-30
ATE429214T1 (de) 2009-05-15
IS2679B (is) 2010-09-15
CY1109154T1 (el) 2014-07-02
GEP20074212B (en) 2007-10-10
ECSP055570A (es) 2006-04-19
OA12875A (en) 2006-09-15
CN1665491A (zh) 2005-09-07
RS112904A (en) 2007-02-05
PL374377A1 (en) 2005-10-17
JP4723243B2 (ja) 2011-07-13
CN100345541C (zh) 2007-10-31
EA007571B1 (ru) 2006-12-29
FR2841140A1 (fr) 2003-12-26
AR040461A1 (es) 2005-04-06
IS7634A (is) 2005-01-07
TNSN04259A1 (fr) 2007-03-12
EP1515704B1 (fr) 2009-04-22
PT1515704E (pt) 2009-05-20
US20060165808A1 (en) 2006-07-27
AU2003260620A1 (en) 2004-01-06
BR0312026A (pt) 2005-03-22
DE60327318D1 (de) 2009-06-04
KR20050023337A (ko) 2005-03-09
FR2841140B1 (fr) 2004-10-01
IL165896A0 (en) 2006-01-15
MXPA05000086A (es) 2005-04-08
HRP20050055A2 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
HK1084043A1 (en) Derivatives of aryl-quinazoline/aryl-2amino-phenylmethanone which promote the release of parathyroidhormone
HRP20050328A2 (en) Process for the preparation of (s,s)-cis-2-benzhyd
AU2003297683A1 (en) Microcapsules with amine adjusted release rates
EP1581160A4 (en) ENCAPSULATION PRODUCTS PROVIDING CONTROLLED OR PROLONGED DELIVERY
AU2003265866A1 (en) Targeted release
EP1490167A4 (en) EQUAL MICRO CAPSULES
AU2003269312A1 (en) Heat spreader
HUP0202414A3 (en) Process for the preparation of perindopril, their analogous and their salts
AU2003268028A8 (en) System for controlling insects
IL163887A0 (en) Controlled release dosage forms
EP1415655A4 (en) IMMUNOTHERAPY FOR PEOPLE
AU2003284484A1 (en) Drug-sustained release carrier
AP2029A (en) Microcapsules for the delayed, controlled release of perindopril
AU2003220466A1 (en) Delayed release dosage forms
AU2003260983A1 (en) Processes for the preparation of s-(-)-amlodipine
PL371375A1 (en) Compounds for the controlled release of active aldehydes
AU2003255890A1 (en) Nitrofurantoin controlled release dosage form
AU2003280634A1 (en) Heat-expandable microcapsules
AU2003267902A1 (en) Spreader
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
IL164788A0 (en) Process for the preparation of 3-isochromanone
MY140099A (en) Microcapsules for the delayed and controlled release of perindopril
AU2003300867A8 (en) Uses of the snorf207 receptor
GB2385868B (en) Ring beams
AU2003200836A1 (en) Method for the preparation of matairesinol